JNJ-1900, an immune-stimulating radiation sensitizer designed to boost the results of hypofractionated radiation in small, focused areas, is being investigated in a part...
Pelabresib plus Rituxan improved spleen measurement and signs in untreated myelofibrosis, assembly the primary objective of the MANIFEST-2 trial.Pelabresib (CPI-0610) remedy together with...